|
WO2000053758A2
(fr)
*
|
1999-03-08 |
2000-09-14 |
Genentech, Inc. |
Compositions et methodes de traitement des maladies immunitaires
|
|
GB9701684D0
(en)
|
1997-01-28 |
1997-03-19 |
Smithkline Beecham Plc |
Novel compounds
|
|
WO2000053751A1
(fr)
*
|
1999-03-08 |
2000-09-14 |
Genentech, Inc. |
Procedes et compositions pour l'inhibition de la croissance de cellules neoplasiques
|
|
US6579520B2
(en)
*
|
1998-05-15 |
2003-06-17 |
Genentech, Inc. |
IL-17 related mammalian cytokine polypeptides (IL-17E)
|
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2000053754A1
(fr)
*
|
1999-03-08 |
2000-09-14 |
Genentech, Inc. |
Compositions et methodes pour le traitement de tumeurs
|
|
US7057017B2
(en)
|
1997-04-16 |
2006-06-06 |
Millennium Pharmaceuticals, Inc. |
Human dickkopf-related protein and nucleic acid molecules and uses therefor
|
|
US6949358B1
(en)
|
1997-06-11 |
2005-09-27 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptor TR9
|
|
US6358508B1
(en)
|
1997-06-11 |
2002-03-19 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor TR9
|
|
CN1270637A
(zh)
*
|
1997-08-08 |
2000-10-18 |
华盛顿大学 |
新的衰老因子基因p23的分离
|
|
US20030166109A1
(en)
|
1997-09-18 |
2003-09-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6391311B1
(en)
*
|
1998-03-17 |
2002-05-21 |
Genentech, Inc. |
Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
|
|
US20030069178A1
(en)
|
1997-10-17 |
2003-04-10 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6455283B1
(en)
|
1998-03-17 |
2002-09-24 |
Genentech, Inc. |
Nucleic acids encoding vascular endothelial cell growth factor-E (VEGF-E)
|
|
US7105640B2
(en)
|
1997-10-17 |
2006-09-12 |
Genentech, Inc. |
Anti-pro792 antibodies
|
|
US20030199674A1
(en)
|
1997-10-17 |
2003-10-23 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6808890B2
(en)
|
1999-07-28 |
2004-10-26 |
Nuvelo, Inc. |
Method of detecting a cancerous cell expressing EGFL6, and EGF mutif protein
|
|
US6392019B1
(en)
|
1997-11-22 |
2002-05-21 |
John Ford |
Antibodies specific for EGF motif proteins
|
|
US8088386B2
(en)
|
1998-03-20 |
2012-01-03 |
Genentech, Inc. |
Treatment of complement-associated disorders
|
|
US7192589B2
(en)
|
1998-09-16 |
2007-03-20 |
Genentech, Inc. |
Treatment of inflammatory disorders with STIgMA immunoadhesins
|
|
EP2014677A1
(fr)
*
|
1997-11-21 |
2009-01-14 |
Genentech, Inc. |
Antigènes apparentés à A33 et leurs utilisations pharmacologiques
|
|
US8007798B2
(en)
|
1997-11-21 |
2011-08-30 |
Genentech, Inc. |
Treatment of complement-associated disorders
|
|
CA2309897A1
(fr)
|
1997-11-22 |
1999-06-03 |
Hyseq, Inc. |
Nouvelle proteine a motifs structuraux du facteur de croissance epidermique obtenue dans une genotheque d'adnc de foie et de rate foetaux
|
|
US7033772B1
(en)
|
1998-01-15 |
2006-04-25 |
Millennium Pharmaceuticals, Inc. |
Methods of identifying inhibitors of fatty acid transport proteins (FATP)
|
|
US7446181B2
(en)
|
1998-01-15 |
2008-11-04 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind human Dickkopf-1 proteins
|
|
US7045333B1
(en)
|
1998-01-16 |
2006-05-16 |
Incyte Corporation |
Human protease molecules
|
|
US6203979B1
(en)
|
1998-01-16 |
2001-03-20 |
Incyte Pharmaceuticals, Inc. |
Human protease molecules
|
|
WO1999040183A1
(fr)
|
1998-02-06 |
1999-08-12 |
Human Genome Sciences, Inc. |
Serine-protease humaine et polypeptides serpin
|
|
US7081521B2
(en)
|
1998-05-06 |
2006-07-25 |
Genentech, Inc. |
Anti-PRO788 antibodies
|
|
US7067636B2
(en)
|
1998-05-06 |
2006-06-27 |
Genentech, Inc. |
Anti-pro 1017 antibodies
|
|
US7488795B2
(en)
|
1998-05-07 |
2009-02-10 |
Genentech, Inc. |
PRO846 polypeptides
|
|
US20030186368A1
(en)
|
1998-05-13 |
2003-10-02 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
EP1865061A3
(fr)
*
|
1998-05-15 |
2007-12-19 |
Genentech, Inc. |
Polypeptides allogéniques IL-17 et utilisations thérapeutiques
|
|
EP3112468A1
(fr)
*
|
1998-05-15 |
2017-01-04 |
Genentech, Inc. |
Polypeptides allogéniques il-17 et utilisations thérapeutiques
|
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
|
CA2328496C
(fr)
|
1998-05-15 |
2016-01-05 |
Genentech, Inc. |
Polypeptides homologues de il-17 et utilisations therapeutiques de ceux-ci
|
|
US7019115B2
(en)
|
1998-05-22 |
2006-03-28 |
Genentech, Inc. |
Pro1017 polypeptides
|
|
US6171843B1
(en)
|
1998-06-01 |
2001-01-09 |
Incyte Pharmaceuticals, Inc. |
Human peptidyl-prolyl isomerases
|
|
AU4682999A
(en)
|
1998-06-16 |
2000-01-05 |
Human Genome Sciences, Inc. |
94 human secreted proteins
|
|
CA2334075A1
(fr)
*
|
1998-07-15 |
2000-01-27 |
Human Genome Sciences, Inc. |
Proteine morphogenetique osseuse
|
|
US7220835B2
(en)
|
1998-07-30 |
2007-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2000012723A1
(fr)
*
|
1998-08-31 |
2000-03-09 |
Long Yu |
Nouveau gene de lysozyme humain, son polypeptide de codage et leur procede de preparation
|
|
KR100866676B1
(ko)
|
1998-09-24 |
2008-11-11 |
파마시아 앤드 업존 캄파니 엘엘씨 |
알츠하이머병 세크레타제
|
|
US6844148B1
(en)
|
1998-09-24 |
2005-01-18 |
Pharmacia & Upjohn Company |
Alzheimer's disease secretase, APP substrates therefor, and uses therefor
|
|
US6699671B1
(en)
|
1998-09-24 |
2004-03-02 |
Pharmacia & Upjohn Company |
Alzheimer's disease secretase, APP substrates therefor, and uses therefor
|
|
WO2000020590A2
(fr)
*
|
1998-10-06 |
2000-04-13 |
Incyte Pharmaceuticals, Inc. |
Proteines de recepteurs couples a des proteines g
|
|
US6960433B1
(en)
|
1998-10-19 |
2005-11-01 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
|
|
EP1127122A2
(fr)
*
|
1998-10-28 |
2001-08-29 |
Incyte Pharmaceuticals, Inc. |
Molecules apparentees au facteur de croissance
|
|
US6432673B1
(en)
|
1998-12-07 |
2002-08-13 |
Zymogenetics, Inc. |
Growth factor homolog ZVEGF3
|
|
AU2162000A
(en)
*
|
1998-12-10 |
2000-06-26 |
Zymogenetics Inc. |
Seven transmembrane domain receptor zsig56
|
|
CA2450402A1
(fr)
*
|
1998-12-22 |
2000-06-29 |
Genentech, Inc. |
Methodes et compositions permettant d'inhiber la croissance de cellules cancereuses avec la pro224
|
|
WO2000039284A1
(fr)
*
|
1998-12-30 |
2000-07-06 |
Millennium Pharmaceuticals, Inc. |
Proteines secretees et acides nucleiques codant ces proteines
|
|
US7456007B1
(en)
|
1998-12-31 |
2008-11-25 |
Elan Pharmaceuticals, Inc. |
β-secretase enzyme compositions and methods
|
|
US7115410B1
(en)
|
1999-02-10 |
2006-10-03 |
Elan Pharmaceuticals, Inc. |
β-secretase enzyme compositions and methods
|
|
WO2000047618A2
(fr)
|
1999-02-10 |
2000-08-17 |
Elan Pharmaceuticals, Inc. |
Compositions a base d'enzyme beta-secretase et procedes
|
|
AU2596700A
(en)
*
|
1999-03-08 |
2000-09-28 |
Genentech Inc. |
Promotion or inhibition of angiogenesis and cardiovascularization
|
|
EP1263948A2
(fr)
*
|
1999-03-08 |
2002-12-11 |
Genentech, Inc. |
Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides
|
|
AU3737500A
(en)
*
|
1999-03-12 |
2000-09-28 |
Genentech Inc. |
Method of preventing the death of retinal neurons and treating ocular diseases
|
|
AU4008500A
(en)
*
|
1999-04-06 |
2000-10-23 |
Eli Lilly And Company |
Platelet-derived growth factor related gene and protein
|
|
JP2003521239A
(ja)
*
|
1999-04-09 |
2003-07-15 |
キュラジェン コーポレイション |
新規ヒトタンパク質およびそれらをコードするポリヌクレオチド
|
|
US7214656B2
(en)
|
1999-04-28 |
2007-05-08 |
Genentech, Inc. |
PRO792 polypeptides
|
|
EP1179052A4
(fr)
*
|
1999-05-07 |
2004-12-15 |
Human Genome Sciences Inc |
Serine proteases
|
|
WO2000068266A1
(fr)
*
|
1999-05-11 |
2000-11-16 |
Eli Lilly And Company |
Protease de proteine precurseur amyloide et composes d'acides nucleiques apparentes
|
|
AU3632600A
(en)
*
|
1999-05-14 |
2000-12-05 |
Genentech Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
CN1244584A
(zh)
*
|
1999-05-14 |
2000-02-16 |
北京医科大学 |
具有免疫细胞趋化和造血刺激活性的趋化因子
|
|
AU5850500A
(en)
*
|
1999-07-08 |
2001-01-30 |
Helix Research Institute |
Fatty acid transporter protein and gene encoding the protein
|
|
US7001766B2
(en)
|
1999-07-20 |
2006-02-21 |
Curagen Corporation |
Nucleic acid sequences encoding human angiopoietin-like polypeptides
|
|
KR100543857B1
(ko)
*
|
1999-09-01 |
2006-01-23 |
제넨테크, 인크. |
혈관신생 및 심혈관형성의 촉진 또는 억제
|
|
CA2389916A1
(fr)
*
|
1999-09-03 |
2001-03-15 |
Human Genome Sciences, Inc. |
Polynucleotides, polypeptides et anticorps de type b7
|
|
US6429303B1
(en)
*
|
1999-09-03 |
2002-08-06 |
Curagen Corporation |
Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same
|
|
CA2384749A1
(fr)
*
|
1999-09-13 |
2001-03-22 |
Curagen Corporation |
Nouvelles proteines humaines, polynucleotides codant celles-ci et procedes d'utilisation des memes
|
|
WO2001021795A2
(fr)
*
|
1999-09-23 |
2001-03-29 |
Whitehead Institute For Biomedical Research |
Proteines de transport d'acides gras
|
|
US6780627B1
(en)
|
2000-01-31 |
2004-08-24 |
Millennium Pharmaceuticals, Inc. |
22438, 23553, 25278, and 26212 novel human sulfatases
|
|
WO2001023569A1
(fr)
*
|
1999-09-29 |
2001-04-05 |
Hyseq, Inc. |
Substances de reception des cytokines, et methodes associees
|
|
US6893637B1
(en)
|
1999-10-21 |
2005-05-17 |
Zymogenetics, Inc. |
Method of treating fibrosis
|
|
EP1232179A4
(fr)
*
|
1999-11-12 |
2003-06-04 |
Human Genome Sciences Inc |
15 proteines humaines secretees
|
|
CA2387805C
(fr)
|
1999-11-18 |
2012-08-28 |
Corvas International, Inc. |
Acides nucleiques codant pour des endotheliases, endotheliases et leurs utilisations
|
|
US7514408B1
(en)
|
1999-12-02 |
2009-04-07 |
Elan Pharmaceuticals, Inc. |
β-secretase enzyme compositions and methods
|
|
US6682902B2
(en)
|
1999-12-16 |
2004-01-27 |
Schering Aktiengesellschaft |
DNA encoding a novel RG1 polypeptide
|
|
ATE444361T1
(de)
*
|
1999-12-23 |
2009-10-15 |
Genentech Inc |
Il-17 und il-17r homologe polypeptide und deren therapeutische verwendungen
|
|
JP2016047051A
(ja)
*
|
1999-12-23 |
2016-04-07 |
ジェネンテック， インコーポレイテッド |
Ｉｌ−１７相同的ポリペプチドとその治療上の用途
|
|
US6610286B2
(en)
|
1999-12-23 |
2003-08-26 |
Zymogenetics, Inc. |
Method for treating inflammation using soluble receptors to interleukin-20
|
|
DK1246846T3
(da)
|
1999-12-23 |
2008-12-08 |
Zymogenetics Inc |
Oplöselig interleukin-20-receptor
|
|
EP1242443A4
(fr)
*
|
1999-12-23 |
2005-06-22 |
Nuvelo Inc |
Nouveaux acides nucleiques et polypeptides
|
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
|
US7122632B2
(en)
|
1999-12-23 |
2006-10-17 |
Zymogenetics, Inc. |
Soluble Interleukin-20 receptor
|
|
AU3086801A
(en)
*
|
2000-01-05 |
2001-07-16 |
Board Of Trustees Of The Leland Stanford Junior University |
Gene involved in mineral deposition and uses thereof
|
|
US7119165B2
(en)
|
2000-01-12 |
2006-10-10 |
Yale University |
Nogo receptor-mediated blockade of axonal growth
|
|
CZ20022438A3
(cs)
*
|
2000-01-12 |
2002-10-16 |
Yale University |
Nukleová kyselina kódující receptor Nogo, izolovaný polypeptid a farmaceutický přípravek pro stimulaci růstu axonů
|
|
AU2001233702A1
(en)
*
|
2000-01-25 |
2001-08-07 |
Novartis Ag |
Disease-associated gene
|
|
AU2001233262A1
(en)
*
|
2000-02-03 |
2001-08-14 |
Dendreon Corporation |
Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
|
|
US6653448B1
(en)
*
|
2000-03-29 |
2003-11-25 |
Curagen Corporation |
Wnt-7B-like polypeptides and nucleic acids encoding same
|
|
US7193050B2
(en)
|
2000-02-18 |
2007-03-20 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
|
WO2001079466A2
(fr)
*
|
2000-04-18 |
2001-10-25 |
Bayer Aktiengesellschaft |
Regulation de la serine protease semblable a l'epithine humaine
|
|
AU2001259271A1
(en)
|
2000-04-28 |
2001-11-12 |
Millennium Pharmaceuticals, Inc. |
14094, a novel human trypsin family member and uses thereof
|
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20020168713A1
(en)
*
|
2000-06-06 |
2002-11-14 |
Curtis Rory A.J. |
46980, a novel human neuroligin family member and uses thereof
|
|
CA2412377A1
(fr)
|
2000-06-06 |
2001-12-13 |
Bristol-Myers Squibb Company |
Acides nucleiques et polypeptides apparentes a b7 utiles pour effectuer une immunomodulation
|
|
US20030031675A1
(en)
|
2000-06-06 |
2003-02-13 |
Mikesell Glen E. |
B7-related nucleic acids and polypeptides useful for immunomodulation
|
|
AU2001268561A1
(en)
*
|
2000-06-15 |
2001-12-24 |
Millennium Pharmaceuticals, Inc. |
22109, a novel human thioredoxin family member and uses thereof
|
|
EP1309620A2
(fr)
*
|
2000-06-23 |
2003-05-14 |
Genentech, Inc. |
Compositions et procedes de diagnose et traitement de maladies faisant intervenir l'angiogenese
|
|
EP2792747A1
(fr)
*
|
2000-06-23 |
2014-10-22 |
Genentech, Inc. |
Compositions et procédés pour le traitement et le diagnostic des troubles impliquant une angiogenèse
|
|
CA2416538A1
(fr)
*
|
2000-07-20 |
2002-01-31 |
Genentech, Inc. |
Compositions et methodes diagnostiques et therapeutiques de troubles impliquant l'angiogenese
|
|
JP2015037408A
(ja)
*
|
2000-07-20 |
2015-02-26 |
ジェネンテック， インコーポレイテッド |
血管形成に関連する障害を診断及び治療するための組成物と方法
|
|
AU2002224546A1
(en)
*
|
2000-07-21 |
2002-02-05 |
Bristol-Myers Squibb Company |
Siglec (sialic acid-binding IG-related lectin) polypeptides and uses thereof
|
|
AU2001290524A1
(en)
|
2000-08-08 |
2002-02-18 |
Zymogenetics Inc. |
Soluble zcytor 11 cytokine receptors
|
|
AU8678501A
(en)
*
|
2000-08-24 |
2002-03-04 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor
|
|
EP1445317A3
(fr)
*
|
2000-08-24 |
2004-12-15 |
Genentech Inc. |
Compositions et procédés de diagnostic et traitement de tumeurs
|
|
EP1327638A4
(fr)
*
|
2000-09-12 |
2004-09-29 |
Kirin Brewery |
Nouvelle membrane a paroi cellulaire dendritique et son utilisation
|
|
ATE333888T1
(de)
|
2000-09-15 |
2006-08-15 |
Zymogenetics Inc |
Verwendung eines polypeptids, welches die extrazelluläre domäne von il-20ra und il-20rb enthält, zur behandlung von entzündungen
|
|
CA2420192A1
(fr)
*
|
2000-09-20 |
2002-03-28 |
Human Genome Sciences, Inc. |
21 proteines humaines secretees
|
|
AU2001237938A1
(en)
*
|
2000-09-20 |
2002-04-02 |
Human Genome Sciences, Inc. |
21 human secreted proteins
|
|
AU2001293046A1
(en)
*
|
2000-09-25 |
2002-04-08 |
Millennium Pharmaceuticals, Inc. |
M32404, a novel human trypsin and uses thereof
|
|
DK1325130T3
(da)
|
2000-10-06 |
2010-05-25 |
Univ Yale |
Nogo-Receptorhomologer
|
|
EP1201681A1
(fr)
*
|
2000-10-30 |
2002-05-02 |
Millennium Pharmaceuticals, Inc. |
Molécules "Fail" et leurs utilisations
|
|
JP2004524821A
(ja)
|
2000-11-06 |
2004-08-19 |
キャンサー・リサーチ・テクノロジー・リミテッド |
疾患のイメージング、診断、及び治療
|
|
US20020111302A1
(en)
*
|
2000-11-30 |
2002-08-15 |
Y. Tom Tang |
Novel nucleic acids and polypeptides
|
|
WO2002057448A1
(fr)
*
|
2000-12-27 |
2002-07-25 |
Daiichi Fine Chemical Co., Ltd. |
Nouveaux peptides et leurs activites
|
|
EP2280030A3
(fr)
|
2001-04-10 |
2011-06-15 |
Agensys, Inc. |
Acides nucléiques et protéines correspondantes utiles dans la détection et le traitement des différents cancers
|
|
US20040038860A1
(en)
|
2002-05-17 |
2004-02-26 |
Allen Kristina M. |
Reagents and methods for modulating dkk-mediated interactions
|
|
CA2448362A1
(fr)
|
2001-05-25 |
2002-12-05 |
Amgen, Inc. |
Molecules de proteine-2 associees a b7 et utilisation de celles-ci
|
|
WO2002101075A2
(fr)
|
2001-06-13 |
2002-12-19 |
Millennium Pharmaceuticals, Inc. |
Identification, evaluation, prevention et traitement du cancer du col de l'uterus : nouveaux genes, nouvelles compositions, nouvelles trousses et nouvelles methodes
|
|
JP4272512B2
(ja)
*
|
2001-06-27 |
2009-06-03 |
キャンサー・リサーチ・テクノロジー・リミテッド |
癌
|
|
AU2002315525A1
(en)
*
|
2001-07-03 |
2003-01-21 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding a transmembrane serine protease 20, the encoded polypeptides and methods based thereon
|
|
WO2003008589A1
(fr)
*
|
2001-07-18 |
2003-01-30 |
Asahi Kasei Kabushiki Kaisha |
Elk1 gene associe a la phosphorylation
|
|
US20030147887A1
(en)
*
|
2001-11-02 |
2003-08-07 |
Shen-Wu Wang |
B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies
|
|
AU2002357283B2
(en)
|
2001-12-17 |
2007-08-16 |
Zymogenetics, Inc. |
Method for treating cervical cancer
|
|
US7202056B2
(en)
|
2002-03-28 |
2007-04-10 |
Bristol-Myers Squibb Company |
Polynucleotides encoding a human cell surface protein with immunoglobulin folds, BGS-19
|
|
EP2275118A3
(fr)
|
2002-05-29 |
2011-10-19 |
DeveloGen Aktiengesellschaft |
Proteines specifiques du pancreas
|
|
EP1565489B1
(fr)
|
2002-06-19 |
2010-11-17 |
Raven Biotechnologies, Inc. |
Anticorps spécifiques pour et qui internalisent la cible de surface cellulaire RAAG10
|
|
JP4869603B2
(ja)
|
2002-11-20 |
2012-02-08 |
キャンサー・リサーチ・テクノロジー・リミテッド |
抗体、ポリペプチドおよびその使用
|
|
US20040203132A1
(en)
|
2003-02-28 |
2004-10-14 |
Cognetix, Inc. |
Conus protein disulfide isomerase
|
|
JP2007525437A
(ja)
|
2003-03-24 |
2007-09-06 |
ザイモジェネティクス， インコーポレイテッド |
抗ｉｌ−２０抗体および結合パートナーならびに炎症において用いる方法
|
|
KR101215218B1
(ko)
|
2003-07-22 |
2012-12-26 |
바이엘 파마 악티엔게젤샤프트 |
Ｒｇ１ 항체 및 그의 용도
|
|
WO2005052001A2
(fr)
|
2003-11-21 |
2005-06-09 |
Zymogenetics, Inc. |
Anticorps du recepteur anti-il-20 et partenaires de liaison et procedes d'utilisation dans l'inflammation
|
|
US7867699B2
(en)
|
2004-03-23 |
2011-01-11 |
Wyeth |
Method of synthesizing and purifying Dkk proteins and Dkk proteins obtained thereby
|
|
BRPI0509420A
(pt)
*
|
2004-04-14 |
2007-09-04 |
Genentech Inc |
método de redução ou inibição da angiogênese e método de aumento da eficácia de tratamento com agente antiangiogênico
|
|
BRPI0510206A
(pt)
*
|
2004-05-12 |
2007-10-16 |
Genentech Inc |
método de identificação de fenótipo, célula isolada, métodos de identificação de agentes, agentes, agentes terapêuticos, método de avaliação de agente terapêutico, composição farmacêutica, métodos de tratamento, prevenção ou melhoria de disfunções e métodos de modulação
|
|
ES2534288T3
(es)
|
2004-08-03 |
2015-04-21 |
Innate Pharma |
Composiciones terapéuticas contra el cáncer que seleccionan como objetivo 4Ig-B7-H3
|
|
WO2006015373A2
(fr)
|
2004-08-04 |
2006-02-09 |
Amgen Inc |
Anticorps contre dkk-1
|
|
AU2005299809B2
(en)
|
2004-10-22 |
2010-12-02 |
Zymogenetics, Inc. |
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
|
|
DE502004006789D1
(de)
|
2004-11-25 |
2008-05-21 |
Roche Diagnostics Gmbh |
Vorrichtung zum Analysieren von Proben
|
|
WO2006056480A2
(fr)
|
2004-11-29 |
2006-06-01 |
Klinikum Der Universität Regensburg |
Moyens et procedes pour la detection d'adn methyle
|
|
WO2006056478A1
(fr)
|
2004-11-29 |
2006-06-01 |
Klinikum Der Universität Regensburg |
Trousses et procedes pour la detection d'adn methyle
|
|
EP1904091A4
(fr)
|
2005-07-07 |
2009-12-23 |
Univ Yale |
Compositions et procedes pour supprimer l'inhibition de la croissance axonale
|
|
US8119387B2
(en)
|
2005-08-16 |
2012-02-21 |
Novozymes A/S |
Polypeptides of strain Bacillus sp. P203
|
|
EP3299027A1
(fr)
|
2005-11-04 |
2018-03-28 |
Genentech, Inc. |
Utilisation d'inhibiteurs de la voie du complément pour traiter les maladies oculaires
|
|
WO2007081608A2
(fr)
*
|
2005-11-21 |
2007-07-19 |
Genentech, Inc. |
Nouvelles dissociations de gènes, compositions et procédés les concernant
|
|
US7776573B2
(en)
|
2006-06-01 |
2010-08-17 |
Genentech, Inc. |
Crystal structure of CRIg and C3b:CRIg complex
|
|
WO2008003748A2
(fr)
*
|
2006-07-07 |
2008-01-10 |
Novo Nordisk A/S |
Polypeptides cd300lg et leur utilisation pour traiter des maladies auto-immunes
|
|
AR063760A1
(es)
|
2006-11-02 |
2009-02-18 |
Genentech Inc |
Anticuerpos anti-factor d humanizados y usos de los mismos
|
|
PE20081760A1
(es)
|
2007-02-09 |
2009-01-01 |
Genentech Inc |
Anticuerpos anti-robo4 y sus usos
|
|
JP2010133705A
(ja)
*
|
2007-03-16 |
2010-06-17 |
Perseus Proteomics Inc |
癌の診断薬及び治療薬
|
|
AR066660A1
(es)
|
2007-05-23 |
2009-09-02 |
Genentech Inc |
Prevencion y tratamiento de condiciones del ojo asociadas con su complemento
|
|
KR101614494B1
(ko)
|
2008-04-02 |
2016-04-22 |
마크로제닉스, 인크. |
Ｂｃｒ-복합체-특이적 항체 및 그것의 사용 방법
|
|
CR20170001A
(es)
|
2008-04-28 |
2017-08-10 |
Genentech Inc |
Anticuerpos anti factor d humanizados
|
|
KR20110025649A
(ko)
|
2008-05-05 |
2011-03-10 |
노비뮨 에스 에이 |
항-ｉｌ-１７ａ／ｉｌ-１７ｆ 교차-반응성 항체 및 그의 사용 방법
|
|
AU2009244300B2
(en)
|
2008-05-06 |
2014-04-17 |
Genentech, Inc. |
Affinity matured CRIg variants
|
|
AR075989A1
(es)
|
2009-04-10 |
2011-05-11 |
Lilly Co Eli |
Anticuerpo dkk -1 (dickkopf-1) humano disenado por ingenieria
|
|
RU2605318C2
(ru)
|
2009-05-05 |
2016-12-20 |
Новиммун С.А. |
Анти-il-17f антитела и способы их применения
|
|
CA2838400A1
(fr)
|
2009-05-08 |
2010-11-11 |
Genentech, Inc. |
Anticorps anti-egfl1 humanises, et procedes d'utilisation correspondants
|
|
CA2761696A1
(fr)
|
2009-05-12 |
2010-11-18 |
Pfizer Inc. |
Anticorps bloquants anti-dkk-1 et leurs utilisations
|
|
CA2769822C
(fr)
|
2009-08-13 |
2019-02-19 |
The Johns Hopkins University |
Methodes de modulation de la fonction immunitaire
|
|
CN107496917B
(zh)
|
2010-02-26 |
2021-06-11 |
诺沃—诺迪斯克有限公司 |
包含稳定抗体的组合物
|
|
LT2542256T
(lt)
|
2010-03-04 |
2019-10-25 |
Macrogenics Inc |
Su b7-h3 reaguojantys antikūnai, jų imunologiškai aktyvūs fragmentai ir jų naudojimas
|
|
US8802091B2
(en)
|
2010-03-04 |
2014-08-12 |
Macrogenics, Inc. |
Antibodies reactive with B7-H3 and uses thereof
|
|
WO2011147921A1
(fr)
|
2010-05-28 |
2011-12-01 |
Novo Nordisk A/S |
Compositions stables multi-doses comprenant un anticorps et un agent conservateur
|
|
US9487587B2
(en)
|
2013-03-05 |
2016-11-08 |
Macrogenics, Inc. |
Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
|
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
|
CN107318267B
(zh)
|
2013-08-12 |
2021-08-17 |
豪夫迈·罗氏有限公司 |
用于治疗补体相关的病症的组合物和方法
|
|
EA201692109A1
(ru)
|
2014-05-01 |
2017-03-31 |
Дженентек, Инк. |
Варианты антител к фактору d и их применение
|
|
US10654932B2
(en)
|
2015-10-30 |
2020-05-19 |
Genentech, Inc. |
Anti-factor D antibody variant conjugates and uses thereof
|
|
EP3368074A2
(fr)
|
2015-10-30 |
2018-09-05 |
Hoffmann-La Roche AG |
Anticorps et conjugués anti-facteur d
|
|
MX2018012433A
(es)
|
2016-04-15 |
2019-03-01 |
Macrogenics Inc |
Moleculas de union b7-h3 novedosas, conjugados anticuerpo-farmaco de los mismos y metodos de uso de los mismos.
|
|
RU2019126483A
(ru)
|
2017-01-23 |
2021-02-24 |
Ридженерон Фармасьютикалз, Инк. |
Варианты 17-бета-гидроксистероиддегидрогеназы 13 (hsd17b13) и их применение
|
|
CN111183234A
(zh)
|
2017-10-11 |
2020-05-19 |
雷杰纳荣制药公司 |
在表达pnpla3 i148m变异的患者的肝病治疗中对hsd17b13的抑制
|
|
CN109708935A
(zh)
*
|
2018-12-15 |
2019-05-03 |
济南艾迪康医学检验中心有限公司 |
一种高分辨外周血染色体g带的制作方法
|